1038
S. Lu, V.W. Pike / Journal of Fluorine Chemistry 131 (2010) 1032–1038
(Fig. 2). [18F]Fluoride ion solution (20
m
L) and xenon difluoride
L/min, into coiled
m i.d., 4-m long; internal volume
L). The reaction mixture from this reactor was then infused
L/min) simultaneously with the 1-((trimethylsilyl)oxy)cyclo-
hexene solution at a rate of 5 L/min into the second micro-reactor
(100 m i.d., 4-m long; internal volume 31.4 L). The effluent from
this reactor was quenched by dilution with acetonitrile (400 L) in a
plastic vial. An aliquot (20 L) of the reaction mixture was analyzed
with HPLC method 1 ([18F]2-fluorocyclohexanone, tR = 5.3 min;
18F]Me3SiF tR = 20.8 min). The radioactive fraction was also
[3] (a) L. Cai, S.Y. Lu, V.W. Pike, Eur. J. Org. Chem. 17 (2008) 2853–2873;
(b) P.W. Miller, N.J. Long, R. Vilar, A.D. Gee, Angew. Chem. Int. Ed. 47 (2008) 8998–
9033;
(c) S.M. Ametamey, M. Honer, P.A. Schubiger, Chem. Rev. 108 (2008) 1501–1506.
[4] (a) T.J. Ruth, A.P. Wolf, Radiochim. Acta 26 (1979) 21–24;
(b) M. Guillaume, A. Luxen, B. Nebeling, M. Argentini, J.C. Clark, V.W. Pike, Appl.
Radiat. Isot. 42 (1991) 749–762.
[5] V. Casella, T. Ido, A.P. Wolf, J.S. Fowler, R.R. Macgregor, T.J. Ruth, J. Nucl. Med. 21
(1980) 750–757.
[6] (a) D.M. Jewett, J.F. Potocki, R.E. Ehrenkaufer, J. Fluorine Chem. 24 (1984)
477–484;
solution were infused simultaneously, each at 5
silica glass micro-reactor 1 (100
31.4
(10
m
m
m
m
m
m
m
m
m
(b) R. Chirakal, G. Firnau, E.S. Garnett, Appl. Radiat. Isot. 39 (1988) 1099–
1101.
[7] (a) R. Filler, Isr. J. Chem. 17 (1977) 71–79;
[
(b) M. Zupan, Xenon halide halogenations, in: S. Patai, Z. Rappaport (Eds.), The
Chemistry of Functional Groups, Suppl. D, John Wiley and Sons Ltd., Chichester,
1983, pp. 657–679;
analyzed by GC (2-fluorocyclohexanone tR = 6.18 min). The
procedure was repeated with the micro-reactors set at different
temperatures.
(c) M.A. Tius, Tetrahedron 51 (1995) 6605–6634;
ˇ
ˇ
(d) M. Tramsek, B. Zemva, Acta Chim. Slov. 53 (2006) 105–116.
[8] E.W. Della, N.J. Head, J. Org. Chem. 57 (1992) 2850–2855.
[9] A.P. Lothian, C.A. Ramsden, Synlett 10 (1993) 753–755.
[10] (a) T.B. Patrick, K.K. Johri, D.H. White, W.S. Betrand, R. Mokhtar, M.R. Kilbourn,
M.J. Welch, Can. J. Chem. 64 (1986) 138–141;
4.6. Reaction of distilled [18F]xenon difluoride with 1-
((trimethylsilyl)oxy)cyclohexene
(b) T.B. Patrick, S. Khazaeli, S. Nadji, K. Hering-Smith, D. Reif, J. Org. Chem. 58
(1993) 705–708.
Anhydrous [18F]FÀ–K+–K 2.2.2 solution (5–20 mCi) in acetoni-
[11] C.A. Ramsden, M.M. Shaw, Tetrahedron Lett. 50 (2009) 3321–3324.
[12] (a) S. Sood, G. Firnau, E.S. Garnett, Int. J. Appl. Radiat. Isot. 34 (1983) 743–
745;
(b) C.-Y. Shiue, K.-C. To, A.P. Wolf, J. Labelled Compd. Radiopharm. 20 (1983)
157–162.
[13] R. Chirakal, G. Firnau, G.J. Schrobilgen, J. Mckay, E.S. Garnett, Int. J. Appl. Radiat.
Isot. 35 (1984) 401–404.
[14] G. Schrobilgen, G. Firnau, R. Chirakal, E.S. Garnett, J. Chem. Soc. Chem. Commun.
(1981) 198–199.
[15] H. Constantinou, F.I. Aigbirhio, R.G. Smith, C.A. Ramsden, V.W. Pike, J. Am. Chem.
Soc. 123 (2001) 1780–1781.
[16] N. Vasdev, B.E. Pointner, R. Chirakal, G.J. Schrobilgen, J. Am. Chem. Soc. 124 (2002)
12863–12868.
trile (ꢁ300
mL) was added to a clear Pyrex glass V-vial (1.0 mL,
Alltech) containing xenon difluoride (2–30 mg; 11.8–177
mmol).
Thereactionmixturewaskeptat90 8Cfor10 min. [18F]XeF2 together
with acetonitrile was distilled over 10 min into another V-vial
containing 1-((trimethylsilyl)oxy)cyclohexene (2–10
tion was allowed to stand at room temperature for 20 min or heated
to 80 8C for5–10 min. Analiquotof the reaction mixture(10 L) was
quenched with acetonitrile (400 L) in a plastic vial (PP LV, 500 L,
Grace). A sample (20 L) was then analyzed with HPLC method 1.
mL). The reac-
m
m
m
m
4.7. Reaction of [18F]xenon difluoride with fluorene in a glass vial in
situ
[17] (a) S.Y. Lu, V.W. Pike, in: P.A. Schubiger, L. Lehmann, M. Friebe (Eds.), PET
Chemistry—The Driving Force in Molecular Imaging, Springer-Verlag, Heidelberg,
2007, pp. 271–287;
(b) H. Audrain, Angew. Chem. Int. Ed. 46 (2007) 1772–1775;
(c) A.M. Elizarov, Lab Chip 9 (2009) 1326–1333;
(d) P.W. Miller, J. Chem. Technol. Biotechnol. 84 (2009) 309–315.
[18] (a) P. Nongkunsarn, C.A. Ramsden, J. Chem. Soc. Perkin Trans. 1 (2) (1996)
121–122;
(b) C.A. Ramsden, R.G. Smith, Org. Lett. 1 (1999) 1591–1594;
(c) M.M. Shaw, R.G. Smith, C.A. Ramsden, J. Fluorine Chem. 116 (2002) 71–73.
[19] C.A. Ramsden, R.G. Smith, J. Am. Chem. Soc. 120 (1998) 6842–6843.
[20] (a) F.C. Cowlard, J.C. Lewis, J. Mater. Sci. 2 (1967) 507–512;
(b) P.J.F. Harris, Philos. Mag. 84 (2004) 3159–3167.
Anhydrous [18F]FÀ–Cs+–K 2.2.2 solution (5–10 mCi) in dichlor-
omethane (200
Alltech) containing xenon difluoride (10–20 mg, 59–118
The reaction mixture was kept at room temperature for 30 min.
Fluorene (1.6 mg, 10 mol) in dichloromethane (50 L) and
BF3.Et2O (1 M, 3 L) were added to the vial. The reaction mixture
m
L) was added to a clear Pyrex glass vial (1.0 mL,
m
mol).
m
m
m
immediately turned from blue to brown and was left standing at
room temperature for 30–60 min. An aliquot of the reaction
[21] M. Iuliano, L. Ciavatta, G. De Tomasso, J. Colloid Interface Sci. 310 (2007) 402–
410.
mixture (10
plastic vial (PP LV, 500
analyzed on a reverse phase HPLC column (Phenomenex, C18, 5
250 mm  4.6 mm) eluted at 1 mL/min with aqueous HCOONH4
(25 mM)-MeCN at 35:65 (v/v). The retention time of [18F]fluoro-
fluorene(s) was 15.1 min. The radioactive product fraction was
collected and analyzed by GC [fluorofluorene(s) tR = 10.4 min].
m
L) was quenched with acetonitrile (300
mL) in a
[22] K.O. Christe, W.W. Wilson, J. Fluorine Chem. 47 (1990) 117–120.
[23] J.R. Ballinger, B.M. Bowen, G. Firnau, E.S. Garnett, F.W. Teare, Int. J. Appl. Radiat.
Isot. 35 (1984) 1125–1128.
[24] J.M. Lehn, J.P. Sauvage, J. Am. Chem. Soc. 97 (1975) 6700–6707.
[25] (a) J.W. Brodack, M.R. Kilbourn, M.J. Welch, J.A. Katzenellenbogen, Appl. Radiat.
Isot. 37 (1986) 217–221;
(b) R.J. Nickles, S.J. Gatley, J.R. Votaw, M.L. Kornguth, Appl. Radiat. Isot. 37 (1986)
649–650.
[26] E.H. Appelman, Inorg. Chem. 6 (1967) 1268–1269.
[27] (a) W.W. Dukat, J.H. Holloway, E.G. Hope, P.J. Townson, R.L. Powell, J. Fluorine
Chem. 62 (1993) 293–296;
m
L, Grace) and a sample (20 L) was then
m
m
,
Acknowledgements
(b) H. Meinert, S.Z. Ru¨diger, Z. Chem. 7 (1967) 239–1239;
(c) L.P. Ingman, J. Jokisaari, K. Oikarinen, R. Seydoux, J. Magn. Reson. 111 (1994)
155–160.
This research was supported by the Intramural Research
Program (project # Z01-MH-002793) of the National Institutes
of Health (National Institute of Mental Health). We are grateful to
the NIH Clinical PET Department for the production of fluorine-18.
We also thank Professor C. A. Ramsden (Keele University, UK) and
Dr. F. I. Aigbirhio (Cambridge University, UK) for their comments
on the draft manuscript.
[28] M.L. Korguth, T.R. DeGrado, J.E. Holden, S.J. Gatley, J. Labelled Compd. Radio-
pharm. 25 (1988) 369–381.
[29] (a) S. Lu, A.M. Giamis, V.W. Pike, Curr. Radiopharm. 2 (2009) 49–55;
(b) J.H. Chun, S. Lu, Y.S. Lee, V.W. Pike, J. Org. Chem. 75 (2010) 3332–3338.
[30] S.M. Qaim, J.C. Clark, C. Crouzel, M. Guillaume, H.J. Helmeke, B. Nebeling, V.W.
Pike, G. Sto¨cklin, in: G. Sto¨cklin, V.W. Pike (Eds.), Radiopharmaceuticals for
Positron Emission Tomography, Kluwer Academic Publishers, Dordrect/London,
Dev. Nucl. Med., vol. 24, 1993, pp. 1–33.
[31] (a) M. Zupan, J. Iskra, S. Stavber, J. Org. Chem. 63 (1998) 878–880;
(b) J. Iskra, S. Stavber, M. Zupan, Collect. Czech. Chem. Commun. 73 (2008)
1671–1680.
References
´
[32] N. Lazarova, F.G. Simeon, J.L. Musachio, S.Y. Lu, V.W. Pike, J. Labelled Compd.
[1] M. Rudin, R. Weissleder, Nat. Rev. Drug Discov. 2 (2003) 123–131.
[2] (a) G. Sedvall, Triangle 30 (1991) 11–20;
Radiopharm. 50 (2007) 463–465.
[33] (a) E.H. Appelman, J.G. Malm, J. Am. Chem. Soc. 86 (1964) 2297–2298;
(b) H. Kunkely, A. Vogler, Inorg. Chim. Acta 357 (2004) 2407–2409.
[34] J.L. Weeks, M.S. Matheson, Inorg. Syn. 8 (1966) 260–264.
(b) T. Jones, Eur. J. Nucl. Med. 23 (1996) 807–813;
(c) J.M. Miller, D. Kumar, J.J. Mann, R.V. Parsey, Curr. Radiopharm. 1 (2008) 12–16.